Ruth Kajander (15 August 1924- 8 November 2019) was a psychiatrist and pioneer in the use of chlorpromazine as a treatment for schizophrenia.[1]

Early life

Ruth Kajander was born Ruth Elisabeth Emilia Auguste Koeppe in Goettingen, Germany in 1924.[2] She was the daughter of Else (née Corman) and Hanskurt Koeppe and had two younger brothers. In her teenage years, during the Second World War, she fled Berlin on bicycle to return to her hometown. In 1948, she completed medical school at Giessen University. In 1957, she married Aatto Arthur Kajander with whom she had one child.[1]

Career

Kajander became the first female intern at the Oshawa General Hospital in 1953. That same year, she learned about the pre-anesthetic chlorpromazine. She realized that the drug sedated patients without putting them to sleep,[1] which opened up the possibility of reducing tension and overactivity in patients with mental illnesses. She administered the drug at the London Psychiatric Hospital in Ontario. This trial involved 25 patients, mostly with symptoms of overactive catatonic schizophrenia. She noted that the drug was effective in improving their quality of life. Although she was the first person in North America to test this drug on psychiatric patients, credit for this contribution went to Heinz Lehmann who was conducting his research around the same time.[3] Kajander presented her findings in November 1953 at the regular meeting of the Ontario Neuropsychiatric Association, months before Lehmann’s first publication.[4] She did not receive formal recognition because her work was not published.[5]

Later in her life, Kajander went on to become the first female president of the Ontario Psychiatric Association in 1982. She was also one of the first women to be involved in the Ontario Medical Association.[1]

Awards

References

  1. 1 2 3 4 "Psychiatrist Ruth Kajander was a pioneer in schizophrenia treatment". The Globe and Mail. 2019-11-24. Retrieved 2023-04-27.
  2. ↑ "Ruth KAJANDER Obituary (1924 - 2019) - Legacy Remembers". Legacy.com. Retrieved 2023-04-27.
  3. ↑ "John Griffith's 1993 Letter to the Editor, "A Historical Oversight"". inhn.org. Retrieved 2023-05-02.
  4. ↑ Stip, Emmanuel (March 2015). "Who Pioneered the Use of Antipsychotics in North America?". Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie. 60 (3 Suppl 2): S5–S13. ISSN 0706-7437. PMC 4418623. PMID 25886681.
  5. ↑ Wasylenki, Donald; Court, John PM; Ostaff, Katherine (2008). A Century of Learning, A Century of Caring: Department of Psychiatry Centenary History, 1907 – 2007. University of Toronto Department of Psychiatry.
  6. ↑ "Too Much Pop Psychology, Not Enough Science in Serious Mental Illness". HuffPost. 2011-07-06. Retrieved 2023-05-02.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.